Ameriprise Financial »

Bright Minds Biosciences shares owned by Ameriprise Financial

Quarter-by-quarter ownership of Bright Minds Biosciences (DRUG) shares owned by Ameriprise Financial from 13F filings

Historical chart of Ameriprise Financial investment in Bright Minds Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Bright Minds Biosciences held by Ameriprise Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bright Minds Biosciences by Ameriprise Financial

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.7M 38k 70.20
2026-03-31 $3.7M 50k 72.97

More positions owned by Ameriprise Financial

NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Lam Research (LRCX)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Bloom Energy Corp (BE)
iShares S&P 500 Index (IVV)
Micron Technology (MU)
Applied Materials (AMAT)
Facebook Inc cl a (META)
Visa (V)
Alphabet Inc Class C cs (GOOG)

View all positions for Ameriprise Financial

Top funds holding Bright Minds Biosciences

Jupiter Topco
Henderson Group
Cormorant Asset Management
BlackRock
Vivo Capital
Vestal Point Capital
Braidwell
Driehaus Capital Management
Balyasny Asset Management
Adage Capital Partners GP
Point72 Asset Management
Deerfield Management Company
RA Capital Management
Parkman Healthcare Partners
MPM Oncology Impact Management

View all funds holding Bright Minds Biosciences